A BILL 
To amend the Internal Revenue Code of 1986 to provide 
for credits against tax for domestic medical and drug 
manufacturing and advanced medical manufacturing 
equipment. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. DOMESTIC MEDICAL AND DRUG MANUFAC-
3
TURING CREDIT. 
4
(a) IN GENERAL.—Subpart D of part IV of sub-
5
chapter A of chapter 1 of the Internal Revenue Code of 
6
1986 is amended by adding at the end the following new 
7
section: 
8
16:15 Aug 15, 2020
H7767
2 
•HR 7767 IH
‘‘SEC. 45U. DOMESTIC MEDICAL AND DRUG MANUFAC-
1
TURING CREDIT. 
2
‘‘(a) IN GENERAL.—For purposes of section 38, the 
3
domestic medical and drug manufacturing credit deter-
4
mined under this section for any taxable year is an amount 
5
equal to 10.5 percent of the lesser of— 
6
‘‘(1) the qualified medical and drug manufac-
7
turing income of the taxpayer for the taxable year, 
8
or 
9
‘‘(2) taxable income of the taxpayer for the tax-
10
able year. 
11
‘‘(b) CREDIT LIMITED TO WAGES PAID.— 
12
‘‘(1) IN GENERAL.—The amount of the credit 
13
allowable under subsection (a) for any taxable year 
14
shall not exceed 50 percent of the W–2 wages of the 
15
taxpayer for the taxable year. 
16
‘‘(2) W–2 WAGES.—For purposes of this sec-
17
tion— 
18
‘‘(A) 
IN
GENERAL.—The 
term 
‘W–2 
19
wages’ means, with respect to any person for 
20
any taxable year of such person, the sum of the 
21
amounts described in paragraphs (3) and (8) of 
22
section 6051(a) paid by such person with re-
23
spect to employment of employees by such per-
24
son during the calendar year ending during 
25
such taxable year. 
26
16:15 Aug 15, 2020
H7767
3 
•HR 7767 IH
‘‘(B) LIMITATION
TO
WAGES
ATTRIB-
1
UTABLE
TO
DOMESTIC
PRODUCTION.—Such 
2
term shall not include any amount which is not 
3
properly allocable to domestic medical and drug 
4
manufacturing gross receipts for purposes of 
5
subsection (c)(1). 
6
‘‘(C) RETURN REQUIREMENT.—Such term 
7
shall not include any amount which is not prop-
8
erly included in a return filed with the Social 
9
Security Administration on or before the 60th 
10
day after the due date (including extensions) 
11
for such return. 
12
‘‘(3) ACQUISITIONS, DISPOSITIONS, AND SHORT 
13
TAXABLE YEARS.—The Secretary shall provide for 
14
the application of this subsection in cases of a short 
15
taxable year or where the taxpayer acquires, or dis-
16
poses of, the major portion of a trade or business or 
17
the major portion of a separate unit of a trade or 
18
business during the taxable year. 
19
‘‘(c) QUALIFIED MEDICAL
AND DRUG MANUFAC-
20
TURING INCOME.—For purposes of this section— 
21
‘‘(1) IN GENERAL.—The term ‘qualified medical 
22
and drug manufacturing income’ for any taxable 
23
year means an amount equal to the excess (if any) 
24
of— 
25
16:15 Aug 15, 2020
H7767
4 
•HR 7767 IH
‘‘(A) the taxpayer’s domestic medical and 
1
drug manufacturing gross receipts for the tax-
2
able year, over 
3
‘‘(B) the sum of— 
4
‘‘(i) the cost of goods sold that are al-
5
locable to such receipts, and 
6
‘‘(ii) other expenses, losses, or deduc-
7
tions which are properly allocable to such 
8
receipts. 
9
‘‘(2) ALLOCATION
METHOD.—The Secretary 
10
shall prescribe rules for the proper allocation of 
11
items described in paragraph (1)(B) for purposes of 
12
determining qualified medical and drug manufac-
13
turing income. Such rules shall provide for the prop-
14
er allocation of items whether or not such items are 
15
directly allocable to domestic medical and drug man-
16
ufacturing gross receipts. 
17
‘‘(3) 
SPECIAL
RULES
FOR
DETERMINING 
18
COSTS.— 
19
‘‘(A) IN GENERAL.—For purposes of deter-
20
mining costs under clause (i) of paragraph 
21
(1)(B), any item or service brought into the 
22
United States shall be treated as acquired by 
23
purchase, and its cost shall be treated as not 
24
16:15 Aug 15, 2020
H7767
5 
•HR 7767 IH
less than its value immediately after it entered 
1
the United States. 
2
‘‘(B) EXPORTS FOR FURTHER MANUFAC-
3
TURE.—In the case of any property described 
4
in subparagraph (A) that had been exported by 
5
the taxpayer for further manufacture, the in-
6
crease in cost or adjusted basis under subpara-
7
graph (A) shall not exceed the difference be-
8
tween the value of the property when exported 
9
and the value of the property when brought 
10
back into the United States after the further 
11
manufacture. 
12
‘‘(4) DOMESTIC MEDICAL AND DRUG MANUFAC-
13
TURING GROSS RECEIPTS.— 
14
‘‘(A) IN
GENERAL.—The term ‘domestic 
15
medical and drug manufacturing gross receipts’ 
16
means the gross receipts of the taxpayer which 
17
are derived from any sale, exchange, or other 
18
disposition of— 
19
‘‘(i) any active pharmaceutical ingre-
20
dient, or 
21
‘‘(ii) any qualified countermeasure, 
22
which was manufactured or produced by the 
23
taxpayer in whole or in significant part within 
24
the United States. 
25
16:15 Aug 15, 2020
H7767
6 
•HR 7767 IH
‘‘(B) ACTIVE
PHARMACEUTICAL
INGRE-
1
DIENT.—The term ‘active pharmaceutical ingre-
2
dient’ means any substance or mixture of sub-
3
stances intended to be used in the manufacture 
4
of a drug product and (when so used) becomes 
5
an active ingredient in the drug product. 
6
‘‘(C) QUALIFIED COUNTERMEASURE.—The 
7
term ‘qualified countermeasure’ has the mean-
8
ing given such term in section 319F–1(a)(2) of 
9
the Public Health Service Act (42 U.S.C. 
10
247d–6a(a)(2)).’’ 
11
‘‘(D) PARTNERSHIPS
OWNED
BY
EX-
12
PANDED
AFFILIATED
GROUPS.—For purposes 
13
of this paragraph, if all of the interests in the 
14
capital and profits of a partnership are owned 
15
by members of a single expanded affiliated 
16
group at all times during the taxable year of 
17
such partnership, the partnership and all mem-
18
bers of such group shall be treated as a single 
19
taxpayer during such period. 
20
‘‘(d) DEFINITIONS AND SPECIAL RULES.—For pur-
21
poses of this section— 
22
‘‘(1) APPLICATION OF SECTION TO PASS-THRU 
23
ENTITIES.— 
24
16:15 Aug 15, 2020
H7767
7 
•HR 7767 IH
‘‘(A) PARTNERSHIPS
AND
S
CORPORA-
1
TIONS.—In the case of a partnership or S cor-
2
poration— 
3
‘‘(i) this section shall be applied at the 
4
partner or shareholder level, 
5
‘‘(ii) each partner or shareholder shall 
6
take into account such person’s allocable 
7
share of each item described in subpara-
8
graph (A) or (B) of subsection (c)(1) (de-
9
termined without regard to whether the 
10
items described in such subparagraph (A) 
11
exceed the items described in such sub-
12
paragraph (B)), and 
13
‘‘(iii) each partner or shareholder 
14
shall be treated for purposes of subsection 
15
(b) as having W–2 wages for the taxable 
16
year in an amount equal to such person’s 
17
allocable share of the W–2 wages of the 
18
partnership or S corporation for the tax-
19
able year (as determined under regulations 
20
prescribed by the Secretary). 
21
‘‘(B) TRUSTS AND ESTATES.—In the case 
22
of a trust or estate— 
23
‘‘(i) the items referred to in subpara-
24
graph (A)(ii) (as determined therein) and 
25
16:15 Aug 15, 2020
H7767
8 
•HR 7767 IH
the W–2 wages of the trust or estate for 
1
the taxable year, shall be apportioned be-
2
tween the beneficiaries and the fiduciary 
3
(and among the beneficiaries) under regu-
4
lations prescribed by the Secretary, and 
5
‘‘(ii) for purposes of paragraph (2), 
6
adjusted gross income of the trust or es-
7
tate shall be determined as provided in sec-
8
tion 67(e) with the adjustments described 
9
in such paragraph. 
10
‘‘(C) REGULATIONS.—The Secretary may 
11
prescribe rules requiring or restricting the allo-
12
cation of items and wages under this paragraph 
13
and may prescribe such reporting requirements 
14
as the Secretary determines appropriate. 
15
‘‘(2) APPLICATION
TO
INDIVIDUALS.—In the 
16
case of an individual, subsection (a)(2) shall be ap-
17
plied by substituting ‘adjusted gross income’ for 
18
‘taxable income’. For purposes of the preceding sen-
19
tence, adjusted gross income shall be determined 
20
after application of sections 86, 135, 137, 219, 221, 
21
222, and 469. 
22
‘‘(3) 
SPECIAL
RULE
FOR
AFFILIATED 
23
GROUPS.— 
24
16:15 Aug 15, 2020
H7767
9 
•HR 7767 IH
‘‘(A) IN GENERAL.—All members of an ex-
1
panded affiliated group shall be treated as a 
2
single corporation for purposes of this section. 
3
‘‘(B) EXPANDED
AFFILIATED
GROUP.— 
4
For purposes of this section, the term ‘ex-
5
panded affiliated group’ means an affiliated 
6
group as defined in section 1504(a), deter-
7
mined— 
8
‘‘(i) by substituting ‘more than 50 
9
percent’ for ‘at least 80 percent’ each place 
10
it appears, and 
11
‘‘(ii) without regard to paragraphs (2) 
12
and (4) of section 1504(b). 
13
‘‘(C) ALLOCATION OF CREDIT.—Except as 
14
provided in regulations, the credit under sub-
15
section (a) shall be allocated among the mem-
16
bers of the expanded affiliated group in propor-
17
tion to each member’s respective amount (if 
18
any) of qualified medical and drug manufac-
19
turing income. 
20
‘‘(4) TRADE
OR
BUSINESS
REQUIREMENT.— 
21
This section shall be applied by only taking into ac-
22
count items which are attributable to the actual con-
23
duct of a trade or business. 
24
16:15 Aug 15, 2020
H7767
10 
•HR 7767 IH
‘‘(5) COORDINATION WITH MINIMUM TAX.—For 
1
purposes of determining alternative minimum tax-
2
able income under section 55, qualified medical and 
3
drug manufacturing income shall be determined 
4
without regard to any adjustments under sections 56 
5
through 59. 
6
‘‘(6) UNRELATED
BUSINESS
TAXABLE
IN-
7
COME.—For purposes of determining the tax im-
8
posed by section 511, subsection (a)(1)(B) shall be 
9
applied by substituting ‘unrelated business taxable 
10
income’ for ‘taxable income’. 
11
‘‘(7) REGULATIONS.—The Secretary shall pre-
12
scribe such regulations as are necessary to carry out 
13
the purposes of this section, including regulations 
14
which prevent more than 1 taxpayer from being al-
15
lowed a credit under this section with respect to any 
16
activity described in subsection (c)(4)(A).’’. 
17
(b) TREATMENT UNDER BASE EROSION TAX.—Sec-
18
tion 59A(b)(1)(B)(ii) of such Code is amended by striking 
19
‘‘plus’’ at the end of subclause (I), by redesignating sub-
20
clause (II) as subclause (III), and by inserting after sub-
21
clause (I) the following new subclause: 
22
‘‘(II) the credit allowed under 
23
section 38 for the taxable year which 
24
is properly allocable to the domestic 
25
16:15 Aug 15, 2020
H7767
11 
•HR 7767 IH
medical and drug manufacturing cred-
1
it determined under section 45U(a), 
2
plus’’. 
3
(c) PART OF GENERAL BUSINESS CREDIT.—Section 
4
38(b) of such Code is amended by striking ‘‘plus’’ at the 
5
end of paragraph (32), by striking the period at the end 
6
of paragraph (33) and inserting ‘‘, plus’’, and by adding 
7
at the end the following new paragraph: 
8
‘‘(34) the domestic medical and drug manufac-
9
turing credit determined under section 45U(a).’’. 
10
(d) CREDIT ALLOWED AGAINST ALTERNATIVE MIN-
11
IMUM TAX.—Section 38(c)(4)(B) of such Code is amended 
12
by redesignating clauses (x) through (xii) as clauses (xi) 
13
through (xiii), respectively, and by inserting after clause 
14
(ix) the following new clause: 
15
‘‘(x) the credit determined under sec-
16
tion 45U,’’. 
17
(e) CLERICAL AMENDMENT.—The table of sections 
18
for subpart D of part IV of subchapter A of chapter 1 
19
of such Code is amended by adding at the end the fol-
20
lowing new item: 
21
‘‘Sec. 45U. Domestic medical and drug manufacturing credit.’’. 
(f) EFFECTIVE DATE.—The amendments made by 
22
this section shall apply to taxable years beginning after 
23
December 31, 2020. 
24
16:15 Aug 15, 2020
H7767
12 
•HR 7767 IH
SEC. 
2. 
QUALIFYING 
ADVANCED 
MEDICAL 
MANUFAC-
1
TURING EQUIPMENT CREDIT. 
2
(a) IN GENERAL.—Subpart E of part IV of sub-
3
chapter A of chapter 1 of the Internal Revenue Code of 
4
1986 is amended by adding at the end the following new 
5
section: 
6
‘‘SEC. 48D. QUALIFYING ADVANCED MEDICAL MANUFAC-
7
TURING EQUIPMENT CREDIT. 
8
‘‘(a) IN GENERAL.—For purposes of section 46, the 
9
qualifying advanced medical manufacturing equipment 
10
credit determined under this section for any taxable year 
11
is the applicable percentage of the basis of any qualifying 
12
advanced medical manufacturing equipment placed in 
13
service during such taxable year. 
14
‘‘(b) APPLICABLE PERCENTAGE.—For purposes of 
15
subsection (a), the applicable percentage is— 
16
‘‘(1) 30 percent in the case of equipment which 
17
is placed in service before January 1, 2028, 
18
‘‘(2) 20 percent in the case of equipment which 
19
is placed in service during calendar year 2028, 
20
‘‘(3) 10 percent in the case of equipment which 
21
is placed in service during calendar year 2029, and 
22
‘‘(4) 0 percent in the case of equipment which 
23
is placed in service after December 31, 2029. 
24
‘‘(c) QUALIFYING ADVANCED MEDICAL MANUFAC-
25
TURING EQUIPMENT.—For purposes of this section, the 
26
16:15 Aug 15, 2020
H7767
13 
•HR 7767 IH
term ‘qualifying advanced medical manufacturing equip-
1
ment’ means property of a character subject to the allow-
2
ance for depreciation— 
3
‘‘(1) which is machinery or equipment that is 
4
designed and used to manufacture a— 
5
‘‘(A) drug (as such term is defined in sec-
6
tion 201(g)(1) of the Federal Food, Drug, and 
7
Cosmetic Act), 
8
‘‘(B) device (as such term is defined in sec-
9
tion 201(h) of such Act), or 
10
‘‘(C) biological product (as such term is 
11
defined in section 351(i) of the Public Health 
12
Service Act), 
13
‘‘(2) which has been identified by the Secretary 
14
(after consultation with the Secretary of Health and 
15
Human Services) as machinery or equipment that— 
16
‘‘(A) incorporates novel technology or uses 
17
an established technique or technology in a new 
18
or innovative way, or 
19
‘‘(B) that can improve medical product 
20
quality, address shortages of medicines, and 
21
speed time-to-market, 
22
‘‘(3) which is placed in service in the United 
23
States by the taxpayer, and 
24
16:15 Aug 15, 2020
H7767
14 
•HR 7767 IH
‘‘(4) with respect to which depreciation is allow-
1
able. 
2
‘‘(d) CERTAIN
QUALIFIED
PROGRESS
EXPENDI-
3
TURES RULES MADE APPLICABLE.—Rules similar to the 
4
rules of subsections (c)(4) and (d) of section 46 (as in 
5
effect on the day before the enactment of the Revenue 
6
Reconciliation Act of 1990) shall apply for purposes of 
7
this section. 
8
‘‘(e) REGULATIONS.—The Secretary shall prescribe 
9
such regulations or other guidance as may be necessary 
10
to carry out the purposes of this section, including regula-
11
tions which prevent abuse or fraud.’’. 
12
(b) TREATMENT UNDER BASE EROSION TAX.—Sec-
13
tion 59A(b)(1)(B)(ii) of such Code, as amended under sec-
14
tion 1 of this Act, is further amended by striking ‘‘plus’’ 
15
at the end of subclause (II), by redesignating subclause 
16
(III) as subclause (IV), and by inserting after subclause 
17
(II) the following new subclause: 
18
‘‘(III) the credit allowed under 
19
section 46 for the taxable year which 
20
is properly allocable to the qualifying 
21
advanced 
medical 
manufacturing 
22
equipment credit determined under 
23
section 48D(a), plus’’. 
24
16:15 Aug 15, 2020
H7767
15 
•HR 7767 IH
(c) PART OF INVESTMENT CREDIT.—Section 46 of 
1
such Code is amended by striking ‘‘and’’ at the end of 
2
paragraph (5), by striking the period at the end of para-
3
graph (6) and inserting ‘‘, and’’, and by adding at the 
4
end the following new paragraph: 
5
‘‘(7) the qualifying advanced medical manufac-
6
turing equipment credit.’’. 
7
(d) CLERICAL AMENDMENT.—The table of sections 
8
for subpart D of part IV of subchapter A of chapter 1 
9
of such Code is amended by adding at the end the fol-
10
lowing new item: 
11
‘‘Sec. 48D. Qualifying advanced medical manufacturing equipment credit.’’. 
(e) EFFECTIVE DATE.—The amendments made by 
12
this section shall apply to periods after the date of the 
13
enactment of this section under rules similar to the rules 
14
of section 48(m) of the Internal Revenue Code of 1986 
15
(as in effect on the date of the enactment fo the Revenue 
16
Reconciliation Act of 1990). 
17
Æ 
16:15 Aug 15, 2020
H7767
